Irbesartan clinical trials angiotensin-receptor blockers

Karvea - Avapro - Aprovel

Acute myocardial infarction

Patients with or without HF:  1 trials  - GLOBAL

Systematic early treatment (with or without sign of HF):  1 trials  - GLOBAL

Atrial fibrillation

2 trials  - ACTIVE I - Madrid

Diabetes type 2

All type of patients:  3 trials  - IDNT (irbesartan vs amlodipine) - IDNT (irbesartan vs pbo) - IPDM (150mg)

Patients with hypertension:  3 trials  - IDNT (irbesartan vs amlodipine) - IDNT (irbesartan vs pbo) - IPDM (150mg)

Patients with or without hypertension:  3 trials  - IDNT (irbesartan vs amlodipine) - IDNT (irbesartan vs pbo) - IPDM (150mg)

Diabetic kidney disease

3 trials  - IDNT (irbesartan vs amlodipine) - IDNT (irbesartan vs pbo) - IPDM (150mg)

Heart failure

All type of patients:  1 trials  - Tonkon et al.

Patients already receiving ACE inhibitor:  1 trials  - Tonkon et al.

Patients with preserved-LVEF heart failure :  1 trials  - I-PRESERVE (McMurray)

Heart failure with preserved LVEF

1 trials  - I-PRESERVE (McMurray)

Hypertension

All diseases requiring ACEi (HF, CHD, HT,...):  2 trials  - IDNT (irbesartan vs pbo) - IRMA 2

All type of patient:  2 trials  - IDNT (irbesartan vs pbo) - IRMA 2

Diabetic patients :  4 trials  - IDNT (irbesartan vs amlodipine) - IDNT (irbesartan vs pbo) - IPDM (150mg) - IRMA 2

Nephropathy:  1 trials  - IDNT (irbesartan vs pbo)

Miscellaneous

2 trials  - IDNT (irbesartan vs pbo) - IRMA 2